NO | Imikhiqizo | Inombolo ye-CAS | Isicelo | Inkomba Yekhwalithi Ebalulekile | ||||
Ubumsulwa | Isomer | Ukungcola okuqondile | *Ubukhulu 1 | Umswakama | ||||
1 | I-Fmoc-Cys(Acm)-OH | 86060-81-3 | Isibopho se-Disulfide | ≥99.0% | ≤0.1% | ≤0.1% | ≤0.2% | ≤1.0% |
2 | I-Fmoc-Cys(Mmt)-OH | 177582-21-7 | Isibopho se-Disulfide | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
3 | I-Fmoc-Cys(4-allylbutyrate)-OH | / | Isibopho se-Disulfide | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
4 | Mpa(Trt)-OH | 27144-18-9 | Ukuphela kokulandelana | ≥99.5% | / | ≤0.1% | ≤0.2% | ≤1.0% |
5 | I-Fmoc-Thr(tBu)-OL | 189337-28-8 | I-Octreotide | ≥97.0% | ≤0.3% | ≤0.5% | ≤1.0% | ≤1.0% |
6 | I-Fmoc-D-Arg(pbf)-OH | 187618-60-6 | I-Desmopressin | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤2.0% |
7 | I-Fmoc-Gly-Gly-OH | 35665-38-4 | I-Bivalirudin | ≥99.5% | / | ≤0.1% | ≤0.2% | ≤1.0% |
8 | I-Fmoc-Gly-Gly-Gly-OH | 170941-79-4 | I-Terlipressin | ≥99.5% | / | ≤0.1% | ≤0.2% | ≤1.0% |
9 | I-Fmoc-Gly-Gly-Gly-Gly-OH | / | I-Bivalirudin | ≥99.5% | / | ≤0.1% | ≤0.2% | ≤1.0% |
10 | I-Fmoc-Gly-Asp(tBu)-OH | / | I-Bivalirudin | ≥99.5% | / | ≤0.15% | ≤0.2% | ≤1.0% |
11 | I-Boc-Cys(Trt)-OH | 21947-98-8 | Ukuphela kokulandelana | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
12 | I-Boc-Arg(pbf)-OH | 200124-22-7 | Ukuphela kokulandelana | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
13 | Boc-Ala-OH | 15761-38-3 | Ukuphela kokulandelana | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
14 | I-Boc-D-Phe-OH | 18942-49-9 | Ukuphela kokulandelana | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
15 | I-Boc-Gly-OH | 4530-20-5 | Ukuphela kokulandelana | ≥99.5% | / | ≤0.1% | ≤0.2% | ≤1.0% |
16 | I-Boc-Ls(Boc)-OH.DCHA | 15098-69-8 | Ukuphela kokulandelana | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
17 | I-Boc-Ser(tBu)-OH | 7738-22-9 | Ukuphela kokulandelana | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
18 | I-Boc-Thr(tBu)-OH | 13734-40-2 | Ukuphela kokulandelana | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
19 | I-Boc-D-Ala-OH | 7764-95-6 | Ukuphela kokulandelana | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
20 | I-Boc-Met-OH | 2488-15-5 | Ukuphela kokulandelana | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
21 | I-Boc-Tyr(tBu)-OH | 47375-34-8 | Ukuphela kokulandelana | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
22 | I-Boc-D-Arg(pdf)-OH | 187618-60-6 | Ukuphela kokulandelana | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
23 | I-Boc-Asp(OtBu)-OH.DCHA | 1913/12/8 | Ukuphela kokulandelana | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
24 | I-Fmoc-HomoArg(pbf)-OH | 1159680-21-3 | I-Eptifibatide | ≥98.5% | ≤0.2% | / | ≤0.5% | ≤2.0% |
25 | I-Fmoc-Asp-OtBu | 129460-09-9 | I-Thymalfasin | ≥99.5% | ≤0.1% | ≤0.1% | ≤0.2% | ≤1.0% |
26 | Fmoc-Tyr(Mina)-OH | 77128-72-4 | I-Carbetocin | ≥98.5% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
27 | I-Fmoc-Orn(Boc)-OH | 109425-55-0 | Atosiban I-Omnipressin I-Daptomycin | ≥99.5% | ≤0.1% | ≤0.1% | ≤0.2% | ≤2.0% |
28 | I-Fmoc-D-Tyr(Et)-OH | 162502-65-0 | Atosiban | ≥99.5% | ≤0.1% | ≤0.1% | ≤0.2% | ≤1.0% |
29 | I-Fmoc-Asp(OAll)-OH | 146982-24-3 | I-Melanotan | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
30 | Ac-Nle-OH | 15891-49-3 | I-Melanotan | ≥99.0% | / | ≤0.3% | ≤0.3% | ≤1.0% |
31 | Fmoc-Nle-OH | 77284-32-3 | I-Melanotan I-Afamelanotide | ≥99.0% | / | ≤0.3% | ≤0.3% | ≤1.0% |
32 | I-Ac-Glu(OtBu)-OH | 84192-88-1 | I-Argireline I-acetyl octapeptide-3 | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
33 | Ac-β-Ala-OH·DCHA | / | I-Acetyl tetrapeptide-5 | ≥99.0% | / | ≤0.3% | ≤0.3% | ≤1.0% |
34 | Fmoc-ß-Ala-OH | 35737-10-1 | I-Acetyl tetrapeptide-5 | ≥99.5% | / | ≤0.1% | ≤0.2% | ≤1.0% |
35 | I-Fmoc-Hyp(tBu)-OH | 122996-47-8 | I-Icatibant | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
36 | Fmoc-Thi-OH | 130309-35-2 | I-Icatibant | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
37 | I-Fmoc-D-Tic-OH | 130309-33-0 | I-Icatibant | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
38 | I-Fmoc-Oic-OH | 130309-37-4 | I-Icatibant | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
39 | Boc-Sar-OH | 13734-36-6 | Saralasin | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
40 | Fmoc-Sar-OH | 77128-70-2 | Saralasin | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
41 | I-Fmoc-Tyr(SO3Na)-OH.H2O | 106864-37-3 | Sincalide | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
42 | I-Fmoc-D-Asp(OtBu)-OH | 112883-39-3 | I-Daptomycin | ≥98.5% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
43 | I-Ac-Ser(tBu)-OH | 77285-09-7 | I-Afamelanotide | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
44 | I-Boc-HomoCys(Trt)-OH | 201419-16-1 | I-Depreotide | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
45 | I-Fmoc-HomoCys(Trt)-OH | 167015-23-8 | I-Depreotide | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
46 | Fmoc-Dab-OH | 161420-87-7 | Ubuhlungu benyoka | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
*I-Max1 = Ubumsulwa obukhulu obungaziwa
Esinye isikhombi:
I-Acetic Acid: ≤0.02% (Yonke Imikhiqizo)
I-Ethyl Acetate: ≤0.5% (Yonke Imikhiqizo)
- Utshwala: ≤0.5% (Yonke Imikhiqizo)
- Ukungcola Okungaziwa Okuphezulu: Fmoc-Trp(Boc)-OH (143824-78-6) ≤0.3%;Abanye ≤0.2%